| Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia M Kołaczkowski, M Marcinkowska, A Bucki, M Pawłowski, K Mitka, ... Journal of medicinal chemistry 57 (11), 4543-4557, 2014 | 69 | 2014 |
| Cracking the chloroquine conundrum: the application of defective UiO-66 metal–organic framework materials to prevent the onset of heart defects—in vivo and in vitro PJ Jodłowski, G Kurowski, Ł Kuterasiński, M Sitarz, P Jeleń, J Jaśkowska, ... ACS Applied Materials & Interfaces 13 (1), 312-323, 2020 | 39 | 2020 |
| Evaluation of 1‐arylpiperazine derivative of hydroxybenzamides as 5‐HT1A and 5‐HT7 serotonin receptor ligands: An experimental and molecular modeling … P Kowalski, J Jaśkowska, AJ Bojarski, B Duszyńska, A Bucki, ... Journal of Heterocyclic Chemistry 48 (1), 192-198, 2011 | 33 | 2011 |
| N‐Alkylation of imides using phase transfer catalysts under solvent‐free conditions J Jaśkowska, P Kowalski Journal of Heterocyclic Chemistry 45 (5), 1371-1375, 2008 | 32 | 2008 |
| Microwave-Assisted Synthesis of Trazodone and Its Derivatives as New 5-HT1A Ligands: Binding and Docking Studies J Jaśkowska, P Zaręba, P Śliwa, E Pindelska, G Satała, Z Majka Molecules 24 (8), 1609, 2019 | 26 | 2019 |
| New Arylpiperazines with Flexible versus Partly Constrained Linker as Serotonin 5‐HT1A/5‐HT7 Receptor Ligands P Kowalski, K Mitka, J Jaśkowska, B Duszyńska, AJ Bojarski Archiv der Pharmazie 346 (5), 339-348, 2013 | 26 | 2013 |
| Zirconium-based metal–organic frameworks as acriflavine cargos in the battle against Coronaviruses─ A theoretical and experimental approach PJ Jodłowski, K Dymek, G Kurowski, J Jaśkowska, W Bury, M Pander, ... ACS applied materials & interfaces 14 (25), 28615-28627, 2022 | 21 | 2022 |
| The synthesis of cyclic and acyclic long‐chain arylpiperazine derivatives of salicylamide as serotonin receptor ligands P Kowalski, J Jaśkowska, AJ Bojarski, B Duszyńska Journal of Heterocyclic Chemistry 45 (1), 209-214, 2008 | 20 | 2008 |
| Design, synthesis and molecular modelling of new bulky Fananserin derivatives with altered pharmacological profile as potential antidepressants P Zaręba, J Jaśkowska, I Czekaj, G Satała Bioorganic & medicinal chemistry 27 (15), 3396-3407, 2019 | 16 | 2019 |
| Chemical puzzles in the search for new, flexible derivatives of lurasidone as antipsychotic drugs P Zaręba, AK Drabczyk, J Jaśkowska, G Satała Bioorganic & Medicinal Chemistry 28 (10), 115459, 2020 | 15 | 2020 |
| Short Communication An Efficient Synthesis of Aripiprazole, Buspirone and NAN-190 by the Reductive Alkylation of Amines Procedure P Kowalski, J Jaskowska Arch. Pharm. Chem 345, 81-85, 2012 | 15 | 2012 |
| Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases D Kułaga, AK Drabczyk, G Satała, G Latacz, K Rózga, D Plażuk, ... European Journal of Medicinal Chemistry 227, 113931, 2022 | 14 | 2022 |
| Solvent-free microwave-assisted synthesis of aripiprazole J Jaśkowska, A Drabczyk, D Kułaga, P Zaręba, Z Majka Curr Chem Lett 7 (3), 81-86, 2018 | 14 | 2018 |
| Aminotriazines with indole motif as novel, 5-HT7 receptor ligands with atypical binding mode D Kułaga, J Jaśkowska, G Satała, G Latacz, P Śliwa Bioorganic Chemistry 104, 104254, 2020 | 12 | 2020 |
| New dual ligands for the D2 and 5-HT1A receptors from the group of 1, 8-naphthyl derivatives of LCAP P Zaręba, J Jaśkowska, P Śliwa, G Satała Bioorganic & Medicinal Chemistry Letters 29 (16), 2236-2242, 2019 | 12 | 2019 |
| Recognition of repulsive and attractive regions of selected serotonin receptor binding site using FMO-EDA approach P Śliwa, R Kurczab, R Kafel, A Drabczyk, J Jaśkowska Journal of Molecular Modeling 25, 1-10, 2019 | 12 | 2019 |
| Ultrasound assisted one-pot synthesis and preliminary in vitro studies of salicylamide arylpiperazines as dual 5-HT1A/5-HT7 ligands J Jaśkowska, AK Drabczyk, P Śliwa, P Jodłowski, E Pindelska, D Kułaga, ... Journal of Molecular Structure 1275, 134585, 2023 | 10 | 2023 |
| Mechanochemical synthesis method for drugs used in the treatment of CNS diseases under PTC conditions J Jaśkowska, AK Drabczyk, P Michorczyk, D Kułaga, P Zaręba, ... Catalysts 12 (5), 464, 2022 | 10 | 2022 |
| Design, synthesis and biological evaluation of novel serotonin and dopamine receptor ligands being 6-bromohexyl saccharine derivatives D Kułaga, J Jaśkowska, G Satała Bioorganic & Medicinal Chemistry Letters 29 (21), 126667, 2019 | 10 | 2019 |
| The influence of Lewis acid catalyst on the kinetic and molecular mechanism of nitrous acid elimination from 5-nitro-3-phenyl-4, 5-dihydroisoxazole: DFT computational study A Łapczuk-Krygier, J Jaśkowska, R Jasiński Chemistry of Heterocyclic Compounds 54, 1172-1174, 2018 | 10 | 2018 |
